Please click "REQUEST A QUOTE" button if there is no stock, or
you need other sizes or custom synthesis.
Catalog:
SLK-S8304
Brand:
Selleck
CAS:
932986-18-0
Overview
MDL
MFCD08009374
Molecular Weight
308.83
Molecular Formula
C15H17ClN2OS
SMILES
CCCC(NCCC1=CSC(C2=CC=C(Cl)C=C2)=N1)=O
For research use only.
Storage
3 years,-20°C,powder 1 years,-80°C,in solvent
Shipping
Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)
Description
Azoramide is a small-molecule modulator of . It improves ER protein-folding ability and activates ER chaperone capacity to protect cells against ER stress.
Azoramide may have the protective effects of enhancing chaperone expression and reducing protein synthesis without inducing cytotoxicity and apoptosis. Azoramide may require the presence of intact IRE1 and PERK branches of the UPR to fully increase chaperone capacity. Azoramide is found to be a kind of compound with the dual property of not only boosting ER folding acutely but also activating ER chaperone capacity chronically to promote ER homeostasis. Its treatment potently protects cells against chemically-induced ER stress conditions. Azoramide preserves beta cell function and survival during metabolic ER stress. Azoramide pretreatment does not impair ER function as part of its initial action. Azoramide treatment leads to increased SERCA expression, resulting in enhanced retention of Ca+2 within the ER. Azoramide interacts with UPR pathways to promote resolution of ER stress and improve ER function.
In vivo
Azoramide improves glucose homeostasis in mice with genetic obesity and diet-induced obesity. Remarkably, azoramide treatment significantly improves insulin sensitivity and glucose tolerance and beta cell function in obese mice in multiple preclinical models.
